Medy-Tox Inc. (KOSDAQ:086900)
121,300
-600 (-0.49%)
Aug 14, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2008 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2008 - 2019 |
Biopharmaceutical Products | 224.77B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biopharmaceutical Products Growth | 3.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2008 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2008 - 2019 |
Other | 235.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 3.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea | 84.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | 5.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | 67.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | -8.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America | 56.52B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America Growth | 17.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 8.54B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 30.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Middle East | 7.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Middle East Growth | -6.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 235.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 3.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oceania | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oceania Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|